₹84.44
+2.33% today
· 30d -9.4%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for BALPHARMA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹89 Cr
+34.53% YoY
NET PROFIT
₹1 Cr
+445.66% YoY
OPM
9.42%
-0.77pp YoY
EPS
₹0.71
PE 18.48
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-50.0%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
60
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
POSITIVE
55
Valuation
CHEAP
75
Growth
MUTED
36
Profitability
DECENT
58
Technicals
WEAK
47
Risk
LOW
90
Key Stats
TTM PE
18.48
P/B
1.62
52W HIGH
₹124.6
OFF HIGH
-32.23%
DIV YIELD
1.44%
MKT CAP
₹135 Cr
◉ Active Signals
MACDNeutral0.2246
RSI(14)Neutral43.62
⧉ Strategy Fit 🔒